Your browser doesn't support javascript.
loading
Idiotype-specific CD4(+) T cells eradicate disseminated myeloma.
Haabeth, O A; Tveita, A; Fauskanger, M; Hennig, K; Hofgaard, P O; Bogen, B.
Afiliação
  • Haabeth OA; Centre for Immune Regulation, Department of Immunology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Tveita A; Centre for Immune Regulation, Department of Immunology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Fauskanger M; Centre for Immune Regulation, Department of Immunology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Hennig K; Centre for Immune Regulation, Department of Immunology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Hofgaard PO; KG Jebsen Centre for Influenza Vaccine Research, Department of Immunology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway.
  • Bogen B; Centre for Immune Regulation, Department of Immunology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Leukemia ; 30(5): 1216-20, 2016 05.
Article em En | MEDLINE | ID: mdl-26449664
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Idiótipos de Imunoglobulinas / Mieloma Múltiplo Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD4-Positivos / Idiótipos de Imunoglobulinas / Mieloma Múltiplo Idioma: En Ano de publicação: 2016 Tipo de documento: Article